SNT
Click for more information
4.65% 4.5¢ syntara limited

News: PXS Boehringer Ingelheim initiates phase IIA study of compound acquired from Pharmaxis

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    24/08/17
    22:15
    Post #: 26742060

    Aug 24 (Reuters) - Pharmaxis Ltd (PXS)

    • Boehringer Ingelheim initiates phase IIA study of compound acquired from Pharmaxis in debilitating liver disease nash
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Drilling at May Queen intersects altered porphyritic rocks and copper sulphides, supporting a large-scale copper-gold system
right-arrow Created with Sketch.
NEWS Shallow high-grade gold hits at Star of Mangaroon and Popeye—see the latest drill results and what’s next
right-arrow Created with Sketch.
NEWS Strong copper-gold surface results confirmed at Fortuna Project, revealing significant mineralisation potential
right-arrow Created with Sketch.
NEWS Major shallow copper-silver discovery at Junction Prospect confirmed with high-grade intercepts
right-arrow Created with Sketch.
NEWS Drilling kicks off at Goldsworthy East—30 holes planned to unlock major westward potential
right-arrow Created with Sketch.
NEWS High-grade antimony mineralization confirmed at Ricciardo with potential 1km strike length
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.5¢ 		Change
0.002(4.65%) 		Mkt cap ! $61.78M
Open High Low Value Volume
4.5¢ 4.6¢ 4.4¢ $251.6K 5.549M

Buyers (Bids)

No. Vol. Price($)
1 14635 4.4¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 239399 2
View Market Depth
Last trade - 15.49pm 02/10/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.